Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study)

This study has been completed.
Sponsor:
Collaborator:
Heart and Stroke Foundation of Ontario
Information provided by:
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00325832
First received: May 12, 2006
Last updated: August 20, 2010
Last verified: May 2008

May 12, 2006
August 20, 2010
January 2006
Not Provided
ambulatory blood pressure
Not Provided
Complete list of historical versions of study NCT00325832 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study)
Not Provided

To determine if the use of automated office blood pressure readings can improve management of systolic hypertension in routine clinical practice. Automated office SBP recordings in routine clinical practice using the BpTRU device will reflect more accurately the mean awake ambulatory systolic BP than will manual BP readings taken with conventional mercury sphygmomanometry. This should lead to improvements in the management of systolic hypertension with optimization of drug therapy in practices using the BpTRU device.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Hypertension
  • Device: BpTRU
  • Device: Conventional mercury sphygmomanometry
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
750
Not Provided
Not Provided

Inclusion Criteria:

  • Both treated and untreated patients with systolic hypertension under routine FP care
  • For untreated patients, routine office SBP as measured by the patient's FP at the last routine office visit using a mercury device must have SBP ≥ 160 mmHg and DBP <= 95 mmHg
  • For patients already receiving antihypertensive therapy, the last routine office BP as measured by the patient's FP using mercury sphygmomanometry must be SBP ≥ 140 mmHg and DBP <= 90 mmHg

Exclusion Criteria:

  • Presence of target organ damage such as MI, stroke, and serum creatinine twice normal
  • Diabetes mellitus treated with insulin or oral hypoglycemic therapy
  • Secondary hypertension
  • Participation in another research study involving measurement of BP
  • Patient's insistence on using self BP measurement outside of the study
  • Any conditions or circumstances which might preclude the successful completion of the study
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00325832
392-2005
No
Not Provided
Sunnybrook Health Sciences Centre
Heart and Stroke Foundation of Ontario
Principal Investigator: Martin Myers, MD Sunnybrook Medical Sciences Centre
Study Chair: Sheldon Tobe, MD Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP